Homburger has advised Credit Suisse and UBS Switzerland in connection with the financing of Farner Consulting in support of its international buy-&-build strategy. Farner Consulting, together with its subsidiaries Rod and DU DA, is the leading agency group for communication consulting in Switzerland. Over the past 10 years, Farner has developed into a fully integrated […]
Anokion, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, recently closed an USD 35 million equity investment from Pfizer through the Pfizer Breakthrough Growth Initiative. Founded in Switzerland and based
The Swiss ETH spin off Akina receives CHF 1,6 million in pre seed capital. Incorporated by two former members of the SMS Lab, Florian Haufe and Michele Xiloyannis in 2021 after years of research in the areas
The Zurich based aspaara has raised CHF 2 million in their seed financing round to build the next generation ERP that is finally human-centric. The start up aspaara is an Artificial Intelligence (AI) platform that optimises
Credit Suisse Group has announced that its board of directors will propose to an Extraordinary General Meeting to be held on 23 November 2022 to approve two separate share capital increases: a first capital increase through the
Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies, a privately owned Swiss company spun out from EPFL. The financing was realised in form of private bonds with warrants which can be
Last September Cornèr Banca has established a CHF 1 billion Covered Bond Programme. The Covered Bonds benefit from a guarantee issued by its subsidiary Accent Ipoteche, indirectly secured by a pool of Swiss residential and
Banking & Finance
Deal & transactions
Lenz & Staehelin: Caceis to acquire European asset servicing activities
CACEIS, the asset servicing banking group of Crédit Agricole and Santander, and Royal Bank of Canada (RBC) has announced that they have signed a Memorandum of Understanding with a view for CACEIS to acquire
Insmed Incorporated, a global biopharmaceutical company, closed a million strategic financing. The company has announced three strategic financings resulting in aggregate gross proceeds of USD 775 million. Proceeds from the transactions will strengthen Insmed’s financial
Accelleron Industries and Turbo Systems Schweiz have entered into a CHF 450 m credit facilities agreement with Credit Suisse Switzerland as mandated lead arranger, agent and original lender. Based in Baden, Accelleron is a renowed company
